SMMT
#823
Summit Therapeutics Inc. - Common Stock
15.3 0 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.33%
Variación mensual
+5.96%
Variación en los últimos 6 meses
-13.17%
Cambio anual
-22.96%
Cierres anteriores
15.2 5
Open
15.3 0
Mínimo
15.3 0
High
15.3 0
Volumen
153
Financials
- Market Capitalization 11.88 B
- Employee 265
- Founded 2003
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-11.92
Relación precio/flujo de caja
-18.9 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 731 |  EXEL Exelixis, Inc. - Common Stock | 56.04 USD | -0.81% | -0.21% | +5.14% | +43.55% | 14.09 B USD | ||
| 809 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 531.00 USD | -1.06% | -0.74% | +10.63% | +25.35% | 12.24 B USD | ||
| 828 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 228.28 USD | -2.36% | -5.79% | -10.25% | +75.33% | 11.75 B USD | ||
| 843 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 59.20 USD | +0.14% | -0.74% | +5.56% | +1.02% | 11.44 B USD |